View in EDS HTML Full Text PDF Full Text

Prognostic and therapeutic considerations of antibodies against c-ter apolipoprotein A-1 in the general population.

Saved in:
Bibliographic Details
Title: Prognostic and therapeutic considerations of antibodies against c-ter apolipoprotein A-1 in the general population.
Authors: Vuilleumier N; Division of Laboratory Medicine Diagnostics Department Geneva University Hospitals Geneva Switzerland.; Department of Medicine Specialties Medical Faculty Geneva University Geneva Switzerland., Antiochos P; Department of Internal Medicine Lausanne University Hospital Lausanne Switzerland., Marques-Vidal P; Department of Internal Medicine Lausanne University Hospital Lausanne Switzerland., Pagano S; Division of Laboratory Medicine Diagnostics Department Geneva University Hospitals Geneva Switzerland.; Department of Medicine Specialties Medical Faculty Geneva University Geneva Switzerland., Virzi J; Division of Laboratory Medicine Diagnostics Department Geneva University Hospitals Geneva Switzerland., Satta N; Division of Laboratory Medicine Diagnostics Department Geneva University Hospitals Geneva Switzerland.; Department of Medicine Specialties Medical Faculty Geneva University Geneva Switzerland., Hartley O; Department of Pathology and Immunology Faculty of Medicine University of Geneva Geneva Switzerland., Gaertner H; Department of Pathology and Immunology Faculty of Medicine University of Geneva Geneva Switzerland., Brandt KJ; Division of Cardiology Foundation for Medical Researches Department of Medical Specialties University of Geneva Geneva Switzerland., Burger F; Division of Cardiology Foundation for Medical Researches Department of Medical Specialties University of Geneva Geneva Switzerland., Montecucco F; First Clinic of Internal Medicine Department of Internal Medicine University of Genoa Genoa Italy.; IRCCS Ospedale Policlinico San Martino Genoa-Italian Cardiovascular Network Genoa Italy., Waeber G; Department of Internal Medicine Lausanne University Hospital Lausanne Switzerland., Mach F; Division of Cardiology Foundation for Medical Researches Department of Medical Specialties University of Geneva Geneva Switzerland., Vollenweider P; Department of Internal Medicine Lausanne University Hospital Lausanne Switzerland.
Source: Clinical & translational immunology [Clin Transl Immunology] 2020 Dec 14; Vol. 9 (12), pp. e1220. Date of Electronic Publication: 2020 Dec 14 (Print Publication: 2020).
Publication Type: Journal Article
Journal Info: Publisher: John Wiley & Sons Australia, Ltd. on behalf of Australasian Society for Immunology Inc Country of Publication: Australia NLM ID: 101638268 Publication Model: eCollection Cited Medium: Print ISSN: 2050-0068 (Print) Linking ISSN: 20500068 NLM ISO Abbreviation: Clin Transl Immunology Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33343896
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Prognostic and therapeutic considerations of antibodies against c-ter apolipoprotein A-1 in the general population.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Vuilleumier+N%22">Vuilleumier N</searchLink>; Division of Laboratory Medicine Diagnostics Department Geneva University Hospitals Geneva Switzerland.; Department of Medicine Specialties Medical Faculty Geneva University Geneva Switzerland.<br /><searchLink fieldCode="AU" term="%22Antiochos+P%22">Antiochos P</searchLink>; Department of Internal Medicine Lausanne University Hospital Lausanne Switzerland.<br /><searchLink fieldCode="AU" term="%22Marques-Vidal+P%22">Marques-Vidal P</searchLink>; Department of Internal Medicine Lausanne University Hospital Lausanne Switzerland.<br /><searchLink fieldCode="AU" term="%22Pagano+S%22">Pagano S</searchLink>; Division of Laboratory Medicine Diagnostics Department Geneva University Hospitals Geneva Switzerland.; Department of Medicine Specialties Medical Faculty Geneva University Geneva Switzerland.<br /><searchLink fieldCode="AU" term="%22Virzi+J%22">Virzi J</searchLink>; Division of Laboratory Medicine Diagnostics Department Geneva University Hospitals Geneva Switzerland.<br /><searchLink fieldCode="AU" term="%22Satta+N%22">Satta N</searchLink>; Division of Laboratory Medicine Diagnostics Department Geneva University Hospitals Geneva Switzerland.; Department of Medicine Specialties Medical Faculty Geneva University Geneva Switzerland.<br /><searchLink fieldCode="AU" term="%22Hartley+O%22">Hartley O</searchLink>; Department of Pathology and Immunology Faculty of Medicine University of Geneva Geneva Switzerland.<br /><searchLink fieldCode="AU" term="%22Gaertner+H%22">Gaertner H</searchLink>; Department of Pathology and Immunology Faculty of Medicine University of Geneva Geneva Switzerland.<br /><searchLink fieldCode="AU" term="%22Brandt+KJ%22">Brandt KJ</searchLink>; Division of Cardiology Foundation for Medical Researches Department of Medical Specialties University of Geneva Geneva Switzerland.<br /><searchLink fieldCode="AU" term="%22Burger+F%22">Burger F</searchLink>; Division of Cardiology Foundation for Medical Researches Department of Medical Specialties University of Geneva Geneva Switzerland.<br /><searchLink fieldCode="AU" term="%22Montecucco+F%22">Montecucco F</searchLink>; First Clinic of Internal Medicine Department of Internal Medicine University of Genoa Genoa Italy.; IRCCS Ospedale Policlinico San Martino Genoa-Italian Cardiovascular Network Genoa Italy.<br /><searchLink fieldCode="AU" term="%22Waeber+G%22">Waeber G</searchLink>; Department of Internal Medicine Lausanne University Hospital Lausanne Switzerland.<br /><searchLink fieldCode="AU" term="%22Mach+F%22">Mach F</searchLink>; Division of Cardiology Foundation for Medical Researches Department of Medical Specialties University of Geneva Geneva Switzerland.<br /><searchLink fieldCode="AU" term="%22Vollenweider+P%22">Vollenweider P</searchLink>; Department of Internal Medicine Lausanne University Hospital Lausanne Switzerland.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101638268%22">Clinical & translational immunology</searchLink> [Clin Transl Immunology] 2020 Dec 14; Vol. 9 (12), pp. e1220. <i>Date of Electronic Publication: </i>2020 Dec 14 (<i>Print Publication: </i>2020).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley+%26+Sons+Australia%2C+Ltd%2E+on+behalf+of+Australasian+Society+for+Immunology+Inc%22">John Wiley & Sons Australia, Ltd. on behalf of Australasian Society for Immunology Inc </searchLink><i>Country of Publication: </i>Australia <i>NLM ID: </i>101638268 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2050-0068 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220500068%22">20500068 </searchLink><i>NLM ISO Abbreviation: </i>Clin Transl Immunology <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33343896
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/cti2.1220
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e1220
    Titles:
      – TitleFull: Prognostic and therapeutic considerations of antibodies against c-ter apolipoprotein A-1 in the general population.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Vuilleumier N
      – PersonEntity:
          Name:
            NameFull: Antiochos P
      – PersonEntity:
          Name:
            NameFull: Marques-Vidal P
      – PersonEntity:
          Name:
            NameFull: Pagano S
      – PersonEntity:
          Name:
            NameFull: Virzi J
      – PersonEntity:
          Name:
            NameFull: Satta N
      – PersonEntity:
          Name:
            NameFull: Hartley O
      – PersonEntity:
          Name:
            NameFull: Gaertner H
      – PersonEntity:
          Name:
            NameFull: Brandt KJ
      – PersonEntity:
          Name:
            NameFull: Burger F
      – PersonEntity:
          Name:
            NameFull: Montecucco F
      – PersonEntity:
          Name:
            NameFull: Waeber G
      – PersonEntity:
          Name:
            NameFull: Mach F
      – PersonEntity:
          Name:
            NameFull: Vollenweider P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 14
              M: 12
              Text: 2020 Dec 14
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-print
              Value: 2050-0068
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Clinical & translational immunology
              Type: main
ResultId 1